{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T18:02:25Z","timestamp":1785088945601,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Circular RNA (circRNAs) functions vital in the pathogenesis and progression of hepatocellular carcinoma (HCC). However, the expressions and functions of certain circRNAs on metastasis and proliferation of that cancer is still unclear. Bioinformation analysis and qRT-PCR indicated that CircC16orf62 was prominent upregulated in HCC of which the expression level was positively associated to cancer\u2019s malignant progression. Gain or loss-of-function studies indicated that the reduction of CircC16orf62 expression promotes the proliferation, invasion, and glycolysis of HCC in vitro and in vivo. The bioinformatic analysis found that miR-138-5p and PTK2 were the downstream target of CircC16or62. Then, the FISH(Fluorescence immunoin situ hybridization) and cell nucleoplasmic separation determined that CircC16orf62 located in the cell cytoplasm. Plasmid vectors or siRNAs were used to change the expression of CircC16orf62, miR-138-5p, and PTK2 in PC cell lines. CircC16orf62 functioned as a molecular sponge for miR-138-5p, and a competitive endogenous RNA for PTK2, promoting AKT\/mTOR pathway activation. Our observations lead us to conclude that CircC16orf62 functions as an oncogene in HCC progression, behaving as a competitive endogenous RNA for miR-138-5p binding, thus activating the AKT\/mTOR pathway. In conclusion, CircC16orf62 is an oncogene through the miR-138-5p\/PTK2\/Akt axis in HCC cells, indicating CircC16orf62 can be a therapeutic target with potentiality for liver cancer and a predictive marker for people with HCC.<\/jats:p>","DOI":"10.1038\/s41419-021-03866-7","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T12:03:51Z","timestamp":1623240231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["CircC16orf62 promotes hepatocellular carcinoma progression through the miR-138-5p\/PTK2\/AKT axis"],"prefix":"10.1038","volume":"12","author":[{"given":"Shuai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Mei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Jing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai-Juan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Ya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0096-3769","authenticated-orcid":false,"given":"Shi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"3866_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Cancer statistics in China, 2015. CA Cancer J. Clin. 66, 115 (2016).","journal-title":"CA Cancer J. Clin."},{"key":"3866_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrm.2015.32","volume":"17","author":"LL Chen","year":"2016","unstructured":"Chen, L. L. The biogenesis and emerging roles of circular RNAs. Nat. Rev. Mol. Cell Biol. 17, 205 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3866_CR3","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1080\/15476286.2016.1220473","volume":"14","author":"S Qu","year":"2017","unstructured":"Qu, S. et al. The emerging landscape of circular RNA in life processes. RNA Biol. 14, 992 (2017).","journal-title":"RNA Biol."},{"key":"3866_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-017-4029-3","volume":"18","author":"T Xu","year":"2017","unstructured":"Xu, T., Wu, J., Han, P., Zhao, Z. & Song, X. Circular RNA expression profiles and features in human tissues: a study using RNA-seq data. BMC Genomics 18, 680 (2017).","journal-title":"BMC Genomics"},{"key":"3866_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1890-9","volume":"10","author":"DD Xiong","year":"2019","unstructured":"Xiong, D. D. et al. High throughput circRNA sequencing analysis reveals novel insights into the mechanism of nitidine chloride against hepatocellular carcinoma. Cell Death Dis. 10, 658 (2019).","journal-title":"Cell Death Dis."},{"key":"3866_CR6","doi-asserted-by":"publisher","first-page":"145365","DOI":"10.1016\/j.gene.2020.145365","volume":"771","author":"G Wei","year":"2021","unstructured":"Wei, G., Zhu, J., Hu, H. B. & Liu, J. Q. Circular RNAs: promising biomarkers for cancer diagnosis and prognosis. Gene 771, 145365 (2021).","journal-title":"Gene"},{"key":"3866_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01298-z","volume":"20","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies. Mol. Cancer 20, 13 (2021).","journal-title":"Mol. Cancer"},{"key":"3866_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fmolb.2017.00038","volume":"4","author":"J Greene","year":"2017","unstructured":"Greene, J. et al. Circular RNAs: biogenesis, function and role in human diseases. Front. Mol. Biosci. 4, 38 (2017).","journal-title":"Front. Mol. Biosci."},{"key":"3866_CR9","doi-asserted-by":"crossref","first-page":"e23049","DOI":"10.1002\/jcla.23049","volume":"34","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. The biogenesis and biological functions of circular RNAs and their molecular diagnostic values in cancers. J. Clin. Lab Anal. 34, e23049 (2020).","journal-title":"J. Clin. Lab Anal."},{"key":"3866_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2183-z","volume":"10","author":"H Hong","year":"2019","unstructured":"Hong, H. et al. The novel circCLK3\/miR-320a\/FoxM1 axis promotes cervical cancer progression. Cell Death Dis. 10, 950 (2019).","journal-title":"Cell Death Dis."},{"key":"3866_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.omtn.2019.09.022","volume":"19","author":"R Ou","year":"2020","unstructured":"Ou, R. et al. circAMOTL1 motivates AMOTL1 expression to facilitate cervical cancer growth. Mol. Ther. Nucleic Acids 19, 50 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"3866_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.omto.2019.12.014","volume":"16","author":"Q He","year":"2020","unstructured":"He, Q. et al. circRNA circFUT8 upregulates Krupple-like factor 10 to inhibit the metastasis of bladder cancer via sponging miR-570-3p. Mol. Ther. Oncolytics 16, 172 (2020).","journal-title":"Mol. Ther. Oncolytics"},{"key":"3866_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.omtn.2020.01.003","volume":"20","author":"R Ou","year":"2020","unstructured":"Ou, R. et al. circRNA-AKT1 sequesters miR-942-5p to upregulate AKT1 and promote cervical cancer progression. Mol. Ther. Nucleic Acids 20, 308 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"3866_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.omtn.2020.08.023","volume":"22","author":"Z Pu","year":"2020","unstructured":"Pu, Z., Xu, M., Yuan, X., Xie, H. & Zhao, J. Circular RNA circCUL3 accelerates the Warburg effect progression of gastric cancer through regulating the STAT3\/HK2 axis. Mol. Ther. Nucleic Acids 22, 310 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"3866_CR15","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.7150\/jca.24566","volume":"9","author":"LP Qiu","year":"2018","unstructured":"Qiu, L. P. et al. The emerging role of circular RNAs in hepatocellular carcinoma. J. Cancer 9, 1548 (2018).","journal-title":"J. Cancer"},{"key":"3866_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3389\/fmolb.2019.00146","volume":"6","author":"A Guria","year":"2019","unstructured":"Guria, A., Sharma, P., Natesan, S. & Pandi, G. Circular RNAs-The Road Less Traveled. Front. Mol. Biosci. 6, 146 (2019).","journal-title":"Front. Mol. Biosci."},{"key":"3866_CR17","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1111\/jcmm.15258","volume":"24","author":"JY Sun","year":"2020","unstructured":"Sun, J. Y. et al. Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma. J. Cell Mol. Med. 24, 5438 (2020).","journal-title":"J. Cell Mol. Med."},{"key":"3866_CR18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jhep.2019.09.010","volume":"72","author":"S Faivre","year":"2020","unstructured":"Faivre, S., Rimassa, L. & Finn, R. S. Molecular therapies for HCC: looking outside the box. J. Hepatol 72, 342 (2020).","journal-title":"J. Hepatol"},{"key":"3866_CR19","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.3390\/ijms19123978","volume":"19","author":"TS Han","year":"2018","unstructured":"Han, T. S., Ban, H. S., Hur, K. & Cho, H. S. The epigenetic regulation of HCC metastasis. Int. J. Mol. Sci. 19, 3978 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"3866_CR20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.21037\/jgo.2016.09.07","volume":"8","author":"DW Kim","year":"2017","unstructured":"Kim, D. W., Talati, C. & Kim, R. Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy. J. Gastrointest. Oncol. 8, 256 (2017).","journal-title":"J. Gastrointest. Oncol."},{"key":"3866_CR21","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3390\/cancers11081085","volume":"11","author":"P Viveiros","year":"2019","unstructured":"Viveiros, P., Riaz, A., Lewandowski, R. J. & Mahalingam, D. Current state of liver-directed therapies and combinatory approaches with systemic therapy in hepatocellular carcinoma (HCC). Cancers 11, 1085 (2019).","journal-title":"Cancers"},{"key":"3866_CR22","first-page":"1002","volume":"10","author":"MS Krishnan","year":"2020","unstructured":"Krishnan, M. S. et al. Genomic analysis of vascular invasion in hepatocellular carcinoma (HCC) reveals molecular drivers and predictive biomarkers. Hepatology 10, 1002 (2020).","journal-title":"Hepatology"},{"key":"3866_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/13645706.2018.1432489","volume":"27","author":"D Gnutzmann","year":"2018","unstructured":"Gnutzmann, D. et al. Transvascular therapy of hepatocellular carcinoma (HCC), status and developments. Minim. Invasive Ther. Allied Technol. 27, 69 (2018).","journal-title":"Minim. Invasive Ther. Allied Technol."},{"key":"3866_CR24","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1101\/gr.255463.119","volume":"30","author":"YJ Chen","year":"2020","unstructured":"Chen, Y. J. et al. Genome-wide, integrative analysis of circular RNA dysregulation and the corresponding circular RNA-microRNA-mRNA regulatory axes in autism. Genome Res. 30, 375 (2020).","journal-title":"Genome Res."},{"key":"3866_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1242\/bio.042937","volume":"8","author":"H Qiu","year":"2019","unstructured":"Qiu, H., Chen, F. & Chen, M. MicroRNA-138 negatively regulates the hypoxia-inducible factor 1alpha to suppress melanoma growth and metastasis. Biol. Open 8, 8 (2019).","journal-title":"Biol. Open"},{"key":"3866_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.biopha.2015.12.018","volume":"77","author":"J Zhang","year":"2016","unstructured":"Zhang, J. et al. MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin. Biomed. Pharmacother. 77, 135 (2016).","journal-title":"Biomed. Pharmacother."},{"key":"3866_CR27","doi-asserted-by":"publisher","first-page":"105195","DOI":"10.1016\/j.phrs.2020.105195","volume":"160","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. PI3K\/AKT\/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma. Pharmacol. Res. 160, 105195 (2020).","journal-title":"Pharmacol. Res."},{"key":"3866_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.canlet.2019.02.040","volume":"450","author":"Z Fan","year":"2019","unstructured":"Fan, Z. et al. PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt\/beta-catenin signaling. Cancer Lett. 450, 132 (2019).","journal-title":"Cancer Lett."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03866-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03866-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03866-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T18:12:08Z","timestamp":1699121528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03866-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["3866"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-03866-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]},"assertion":[{"value":"1 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of The Affiliated Cancer Hospital of Guizhou Medical University, and informed consent was obtained from all participants included in the study, in agreement with institutional guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"597"}}